MRNA 全部观点

已加载 20 条观点条目,其中 0 条方向发生变化

在已加载记录中筛选
Schwab Network发布 2026-11-05
《The Big 3: HCA, ISRG, MRNA》
$MRNA中性
AI 摘要 · 说话者看好MRNA,理由是III期数据显示一款与Keytruda合作的药物使皮肤癌相关死亡减少约42%,且自今年年初以来呈上升趋势,但并非长期上升趋势。不过该股在255附近旧高点受阻,RSI在上升与下降趋势线之间方向未明;需突破任一侧才能明确看涨或看跌方向,若跌破238.25的5日EMA可能打开219。

你这里的下一个名字也属于医疗保健板块,但它是一家制药公司,跌幅比一些其他公司稍大,Moderna下跌了4.3%,今年迄今为止它经常登上头条。

Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.

Moderna的大局:大家都通过其新冠疫苗认识他们,但他们也在做一些很酷的事情,比如与Keytruda的合作,以及他们提供的一种已进入第三阶段的药物,目前显示它可以将皮肤癌相关死亡减少约42%。

所以,这是好消息。因此,我在长期趋势中看好Moderna,我不该说长期上升趋势。自今年年初以来,它一直处于上升趋势。

Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.

So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.

Meet Kevin发布 2026-11-04
《The Stock Market & Morning After Election 2026.》
$MRNA看涨
Meet Kevin发布 2026-10-31
《You've been WARNED.》
$MRNA看涨
Benzinga发布 2026-10-30
《$INTC Plunges 26%, $AMZN Drops 6% After Q3 Earnings | PreMarket Playbook | October 30, 2026》
$MRNA看跌
AI 摘要 · MRNA 不是一只值得持有的股票:它从未赚过钱,是一家“忽悠”公司,不过日内进出交易尚可。它此前表现强劲——上涨 545%,随后 William Blair 将其下调至 market perform——而 180 是良好的逢低买入点。

MRNA,只跌了几个点。

MRNA, only down a couple.

哇。MRNA。对。mRNA 在哪?mRNA 没有下跌。William Blair 对 Madna 股票出手,在上涨 545% 之后将评级下调至 market outperform。

那是 10 月 27 日,所以那不是,对,那看起来确实很强。

Wow. MRNA. Yeah. Where is mRNA? mRNA is not going down. William Blair takes a shot at Madna stock downgrade to market outperform after 545% run. That was October 27th, so that's not Yeah, that that looks strong for sure.

你觉得 MNA、MRNA 怎么样?它就是看起来不错。180 那次真是绝佳的逢低买入机会。我在 180 进场了。不过它从 240 因消息泄露而下跌时,我持有得不够久。那是一个很好的机会。

Uh, what do you think of MNA MRNA? It's just looking good. You know, that was such a buy the dip at 180. I got involved at 180. I didn't hold it long enough though when it went down from 240 on the leaked news. That was that was a good opportunity.

The Motley Fool发布 2026-10-23
《Moderna CEO Reveals His Massive Plans for Cancer, AI & Beyond!!》
$MRNA看涨
AI 摘要 · 主持人预计会继续加仓其Moderna持仓,认为市场对其平台定价有误:按行业通常10%的获批率,该股会被高估,但该平台应能提升其在每个新疾病领域的成功率,且自身免疫领域的价值尚未反映在股价中。

因为我们只有3个小时,我就直接开始提问了。好,我们先来解释一下 Moderna 的基础技术,用连一个讨厌科学的十年级学生都能听懂的方式来解释。

Since we only have 3 hours, I'll start asking questions right away. Okay, let's start by explaining Moderna's basic technology in a way that a tenth-grade student who hates science can understand.

哦,得了吧。高中时你不可能讨厌科学。很简单,正如你们很多人在疫情期间了解到的,信使RNA(mRNA)是一种信息分子。它由四个字母组成,就像所有软件都由0和1组成一样。

Oh, come on, man. You can't hate science in high school. Well, very simply, as many of you have learned during the pandemic, messenger RNA (mRNA) is an information molecule. It consists of four letters, just as all software consists of zeros and ones.

Schwab Network发布 2026-10-23
《Friday's First Moves: MRNA Cancer Vaccine Trial Leaks, DECK Earnings, NCLH Downgrade》引用来源:analysts
$MRNA中性
AI 摘要 · MRNA 下跌5.5%,起因是后期癌症疫苗阳性数据泄露(相较单用 Keytruda,复发/死亡风险相对降低42%)——这并非糟糕的结果。分析师认为这是“买传闻、卖新闻”:该股一年内上涨600%,已提前计入突破性进展,因此此次下跌看起来像是在官方三期结果公布前的获利了结。

Diane King Hall和我一起来看Moderna。我们昨天稍微谈过这个。昨天出现了一轮剧烈而戏剧性的抛售。

Diane King Hall is joining me to take a look at Moderna . We talked a little about this yesterday. It was an intense and dramatic sell-off yesterday.

昨天,这导致市值减少了240亿美元。Moderna今天仍面临压力。但这并不意味着业绩很差。这些压力出现在有关癌症疫苗试验的一些信息被泄露之后。我们原本预计它会在本周末发布。它仍计划在本周末发布。

Yesterday, this resulted in a $24 billion reduction in market value. There is ongoing pressure on Moderna today. But that doesn't mean the results were bad. These pressures come after some information regarding cancer vaccine trials was leaked .

We were expecting it to be released at the end of this week. It is still scheduled to be released at the end of this week.

他说在等
官方三期癌症疫苗结果发布
结果证实此前泄露的42%相对风险降低
本周末定于本周末发布的官方三期结果
支持这一观点:此次抛售是获利了结,而非数据不佳
Schwab Network发布 2026-10-23
《WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak》
$MRNA中性
AI 摘要 · Moderna 泄露的三期癌症疫苗数据显示,复发/死亡风险降低42%,而预期为40%;有人曾期待超过50%,且生存数据尚未泄露。股价下跌部分源于此前大幅上涨;说话者认为泄露的结果总体偏正面,仍有待本周末公布的最终结果。

好,接下来我们谈谈纳斯达克指数中的一只重要股票。不是今天,而是昨天。这家公司是Moderna。这与这里的科技股交易完全是两回事。在本周末将要发生的事情之前,市场情绪非常乐观。我们本应获得癌症疫苗试验的结果。

我们已经拿到了第一阶段和第二阶段的结果。昨天有一则消息泄露,导致股价下跌。请给我们讲讲这里正在发生的一些价格走势。

Okay, let's move on to talking about a big stock in the Nasdaq index. Not so much today, but yesterday. This is the company "Moderna". It's a completely different story from technology stock trading here.

There was a lot of optimism ahead of what would happen this weekend. We are supposed to get the results of the cancer vaccine trials. We have obtained the first stage and the second stage.

There was a leak yesterday that caused the stock to drop. Tell us about some of the price movements that are happening here.

他说在等
本周末公布的3期试验最终结果,包括生存数据
生存数据达到或超过部分投资者所期望的50%以上这一数字
本周末ESMO会议上公布的试验最终结果
支持说话者整体偏正面的解读
Meet Kevin发布 2026-10-20
《The NEXT Frontier: THESE 3 Stocks Boom》
$MRNA看涨
AI 摘要 · MRNA是值得长期看涨的持仓:AI将癌症靶点筛选从60天缩短至两周,使癌症治疗更快、更便宜。10月24日周六的3期临床数据发布是最近的催化剂,也可能令人失望;MRNA依赖这一单一疗法,糟糕的报告可能使其跌回底部。

Moderna 这个周六有一场会议。那将是一场演示,他们故意选在市场休市时进行。演示将在 10 月 24 日举行。这是最近的催化剂,即他们三期癌症治疗数据的更新。

Moderna has a meeting coming up this Saturday. It will be a presentation, and they deliberately do this when the market is closed. It will be a presentation on October 24th. This is the closest catalyst, an update to their Phase 3 cancer treatment data,

那么,Moderna 是做什么的?Moderna 基本上是说:“嘿,我们来检查某人的癌症。我们从癌症中取一个实体细胞,用手术切下一部分。我们做一次活检。”所以,我们要对癌细胞做活检。

然后,我们要做的是基因组测序……天哪。我们要对它做基因组测序,这是一长串基因数据。想想字母 T、A、C。还记得你学生物的时候吗?我们要做的是,在那个癌细胞里找到我们可以靶向摧毁的基因组部分,这当然意味着我们不想靶向那些一旦被靶向就可能杀死你的基因组部分。

显然,这是个问题。我们要靶向那个癌细胞独有的基因组部分。问题在于,癌细胞一直在突变,不断变化。因此,这个基础基因组变化很大。所以,我们要做的是靶向 32 个不同的部分。只要其中任何一个部分存活下来,我们仍然能够靶向那个癌细胞。

我们要做的是,把这些小部分注入你的体内,也许在 12 个月的疗程中注射七次。我们会训练你的身体。我们不会深入讲背后的确切科学,因为涉及蛋白质折叠以及预测淋巴结内最终会发生什么,会有点复杂。

简单说,有一些小载体,好吗?这些小载体将针对这 32 个部分接受训练。这 32 个小部分会被取来,附着在它的外表面。你把它带到你的淋巴系统,对它说:“你看到我们这里所有这些小凸起了吗?

消灭它们。消灭我们携带的这些小的蛋白质。识别它们并消灭它们。”然后你的淋巴系统会说:“我们不喜欢这个。我们要……我们要……我们要……做一个鬼脸。好了,一个鬼脸。我们要去追那些小凸起。”

这些凸起真的很难识别,而这就是人工智能的用武之地。因为它们可以游走你的全身,定位它们,追踪那个癌细胞并消灭它,防止它扩散到你身体的其他部位,对吧?整个思路是,即使那个癌细胞在突变或进化,只要我们还有那些剩余部分中的一个,我们仍然能识别它。

这就是思路。问题在于,这个筛选过程过去大约需要 60 天,而且你只能得到两个,也许只有两个部分。好吗?多亏了人工智能,这已经改变了。现在人工智能来了,说:“我们可以在大约两周内完成其中很多工作。”

我们可以得到 32 个预期芯片,我们确实相信它们会:第一,消灭癌症;第二,不会要你的命。这两件事都挺重要的,不是吗?因此,人工智能加快了这个过程所需的时间。

So, what does Moderna do? Moderna basically says: " Hey, let's examine someone's cancer. We'll take a solid cell from the cancer, and we'll surgically remove part of it. We'll take a biopsy."

So, we're going to take a biopsy of, you know, a cancer cell. And then, what we're going to do is genome sequencing...oh my god. We will be doing a genome sequence for that, which, as you know, is a very long series of genetic data.

Think of the letters T, A, and C. Remember your biology days, right? What we will try to do is try to find in that cancer cell parts of its genome that we can target to destroy it, which of course means that we do not want to target parts of that genome that, if targeted, could kill you.

Obviously, this is a problem. We want to target parts of that genome that are unique to that cancer cell . The problem is that cancer cells mutate all the time. It's constantly changing.

Therefore, this basic genome changes a lot. Therefore, what we will do is target 32 different parts. If any one of these parts survives, we will still be able to target that cancer cell.

What we will do is we will inject these small parts into your body, perhaps seven times over a 12-month course. We will train your body. We won't go into the exact science behind it, because it gets a bit complicated with protein folding and predicting what ultimately happens inside your lymph nodes.

Simply put, there are small carriers, okay? These small carriers will be trained on these thirty-two parts . These thirty-two small parts will be taken and attached to its outer surface.

You will take it to your lymphatic system and say to it, "Do you see all these little bumps we have here? Eliminate them. Eliminate these little proteins we are carrying. Identify them and eliminate them."

And then your lymphatic system will say: "We don't like this. We're going to ...we're going to ...we're going to... make a face. There we go . A face. We're going to go after those little bumps."

Well, these bumps are really hard to identify, and that's where artificial intelligence comes in. Because they can travel throughout your entire body, locate them, track down that cancerous cell and eliminate it to prevent it from spreading to the rest of your body, right?

The whole idea is that even if that cancer cell is mutating or evolving, as long as we have one of those remaining parts , we can still identify it. That's the idea. The problem is that this selection process used to take about 60 days, and you would only get two of them.

Maybe only two parts. Good? That has changed thanks to artificial intelligence. Now artificial intelligence comes along and says, "We can do a lot of this in about two weeks." We can get 32 expected chips that we actually believe will: first, eliminate cancer, and second, will not end your life.

Both things are somewhat important, aren't they? Therefore, artificial intelligence speeds up the time it takes to do this,

他说在等
10月24日周六报告会上的3期癌症治疗数据
确认该治疗取得成功的积极3期数据
10月24日10月24日周六报告会
支持看涨观点;若报告不佳则会削弱该观点
Brian Shannon发布 2026-10-20
《Brian Shannon on TraderTV Live 10/20/26》
$MRNA中性
AI 摘要 · MRNA 目前太贵;若回调至 210 可能是买入机会,但跌破 210 则有更深下跌风险,而一旦跌破关键的高位低点,可能回落至 50。上升趋势仍完好,守住上升的锚点和向上倾斜的 20 日均线;高波动加大了回调风险,但目前尚未出现回调迹象。

我们的一位忠实观众,聊天室里的Arun Warrior,想多了解一些Moderna的情况。我们喜欢Moderna的故事,对吧?mRNA。我的意思是,嗯,与Merck合作在癌症方面取得了多么巨大的进展,而现在有点……

我不知道。我们只能看看这对未来意味着什么。但这只股票确实对那个峰值做出了反应。

One of our loyal viewers, Arun Warrior in the chat , would like to know a bit more about Moderna . We love the story of Moderna, don't we? mRNA. I mean, um, what a tremendous rise with Cancer, together with Merck, and now a bit...

I do n't know. We will just have to see what that means for the future. But the stock really responded to the peak.

Meet Kevin发布 2026-10-20
《The Pain Returns... ALREADY AI, Fed, Iran, SpaceX》引用来源:Bank of America
$MRNA看涨
AI 摘要 · MRNA是一个看多但二元化的押注:他有敞口,在135至145附近买入,并对10月24日3期癌症疗法数据更新、AI带来的成本与时间改善以及可能扩展到其他癌症感到兴奋;BofA的目标价为220,但它承担单一试验风险,周六一份糟糕的报告就可能把它打回地板。

我的意思是,Q's 撑住了。看看那波反弹。那是 VWAP 反弹吗?嗯哼。对。完美的 VWAP。

I mean, the Q's are holding. Look at that bounce. Was that a VWAP bounce? Uh-huh. Yeah. Perfect VWAP.

我们这里会提到的一些股票将是 Tempest AI、Mona 和 Eli Liy。现在,我想说清楚,这三家里,我持有其中两家的敞口。

Some of the stocks we'll touch on here are going to be Tempest AI, Mona, and Eli Liy. Now, I want to be clear out of these three, I've got exposure to two of them.

首先要了解的是,Merna 这个周六有一场会议。那将是一场演示。他们特意选在市场休市的时候进行。演示将在10月24日举行。这是最近的催化剂,也是关于其癌症疗法3期数据的最新进展,该疗法是 mona 与 merks 合作开发的 keduda 癌症疗法或免疫疗法药物,用于对抗4期黑色素瘤并降低全身转移扩散的风险。

So the first thing to know is that Merna has a meeting coming up this Saturday. Uh it is going to be a presentation. They purposefully do it when the market is closed. Is going to be a presentation on October 24th.

It's the nearest catalyst and it is an update on phase 3 data for their cancer therapy which is the partnership between uh mona and merks keduda cancer therapy or amunotherapy drug uh in fighting stage 4 melanoma and minimizing the risk of spread throughout your body metastasis.

他说在等
10月24日3期癌症治疗数据演示
正面的3期更新,而非糟糕的报告
10月24日星期六10月24日演示
正面更新支持看涨观点;糟糕的报告可能使股价跌回底部
Verified Investing发布 2026-10-16
《Tesla Unveils a Flying Car, Then Stock CRASHES》
$MRNA看跌
AI 摘要 · Moderna 因其皮肤癌药物推进至下一试验阶段而大涨约 200%,经过盘整后再度走高,但刚刚录得自那次大涨以来最大的阴线,且 RSI 与更高的价格高点形成看跌背离;若出现下跌他不会意外,也不会逆势对抗这一走势。

我们来看一下SpaceX和Moderna,

We'll take a look at SpaceX and Moderna,

然后我们有一根“治愈癌症”蜡烛,对吧?或者说是那里蜡烛的跳跃。好,这是Moderna。你看,他们获得了治疗皮肤癌的好疗法,进入下一个试验。当然,皮肤癌药物进入了下一阶段试验。股票基于这个消息跳涨。

Then we have a "cancer cure" candle, right? Or that leap in the candle there . Okay, this is Moderna. You see that they got that good treatment for skin cancer, you know, move on to the next trial.

The skin cancer drug, of course, moved on to the next phase of trials. The stock jumped based on that news.

Brian Shannon发布 2026-10-06
《Brian Shannon on TraderTV 10/6/26》
$MRNA看跌
AI 摘要 · MRNA可能面临短期下跌/洗盘;关键支撑位于20日均线(约173-174),若跌破则下一目标位约152。

这就对了。所以,正如你所说,我们已经看到了 Nike 的底部。还有另一个诉求,是几周前的。所以如果你不记得,我原谅你,但你记得 Moderna 130 吗?记得。所以,那就是那个支撑水平,Moderna 的突破。

现在,我们在这里有了一个三重顶。你突破了高点,你触及了三重顶。这些当然不是历史新高;疫情期间它更高,但你有一个三重顶。我们今天在这个板块看到了显著的投降式抛售。所有东西都高开,随后被彻底惩罚。

今天成交量不算巨大,但这是一次明确的拒绝。那么,你现在对 Moderna 有什么预期?有没有下一个进场水平,因为它显然仍处于上升趋势,而且既然它表现这么好,每个人都想知道下一步是什么。

There you go. So, we have seen the bottom of Nike, as you said, as you said . There is another appeal, and it is from a few weeks ago. So I forgive you if you don't remember this, but do you remember Moderna 130?

Yes. So, that was that support level, the breakout at Moderna. At this point, we now have a triple top here. You broke out above the peak, you hit a triple top. These are of course not all-time highs; it was higher during COVID, but you have a triple top.

We saw a significant capitulation in this sector today. Everything was opened higher and was subsequently fully punished. It wasn't a huge volume today, but it was a clear rejection.

So, what do you expect for Moderna now? Is there a next entry level, because it is clearly still in an upward trend and everyone is wondering what the next step is, since it has performed so well.

Schwab Network发布 2026-09-30
《Wednesday's First Moves: MRNA Downgrade, BA Jet Contract, JBL Earnings》引用来源:Citigroup
$MRNA看跌
AI 摘要 · MRNA 应予卖出;Citi 将其下调至卖出,目标价 80 美元(下行空间超过 60%),因癌症试验推动的 200% 涨幅已被充分定价,且估值假设了未来肿瘤领域的过度成功。

我们将 Moderna 视为一个“卖出”标的。花旗今天给予其“卖出”评级。此前 Moderna 近期表现强劲,得益于一些积极的试验结果。他们将其评级从“中性”下调至“卖出”。与此同时,他们上调了该股的目标价,但仅上调至 80。

这是从 60 上调而来。因此,在今天之前,他们的展望并不十分乐观。这意味着较昨日收盘水平有超过 60% 的潜在下跌空间。

We view Moderna as a "sell" product. Citigroup gave it a "sell" rating today. This comes after Moderna's recent strong performance, thanks to some positive trial results . They have downgraded its rating to "Sell" from " Neutral".

At the same time, they raised the target price for the stock, but only to 80. This is a rise from 60. So, their outlook wasn't very positive before today. This means a potential drop of more than 60% from yesterday's closing levels.

Brian Shannon发布 2026-09-29
《Brian Shannon on TraderTV Live 9/29/26》
$MRNA中性
AI 摘要 · MRNA 的动能难以预测;若突破 190,可能先回落至 175,之后才会进一步上行。

有一位观众提了个问题。他问你怎么看mRNA,以及这个牛旗是怎么形成的。你认为会有延续,还是认为动能会慢慢消退?

there is a question from one of our viewers. He asked what you think of mRNA and how this bull flag originated. Do you think there will be a continuation, or do you think the momentum will slowly fade?

我看着它说,没有人能预测动能会在哪里消退。所以反过来,我看着它说:看30分钟时间框架,在被证明有罪之前它是无罪的。它沿着这条上行的5日移动平均线运行。所以我会说,你应该关注这条5日移动平均线上方最近的相关更高低点。

所以我认为,如果我们突破190,mRNA最可能的情形是出现类似这样的走势:也许我们开始分化,跌破这里的那个更低的底部,看到一个更低的顶部,卡在5日均线下方,然后也许向175回落一点,之后就准备好再次上涨。

I look at it and say that no one can predict where the momentum will fade. So instead, I look at it and say: look at the 30-minute timeframe, and it is innocent until proven guilty.

It moves along with this rising 5-day moving average. So I would say that you should look at the most recent relevant higher low above that 5-day moving average. So I think that if we break through the 190, the most likely scenario for mRNA is that it does something like this: maybe we start to divide, break through that lower bottom here, see a lower top, get stuck below the 5-day average, and then maybe pull back a bit towards the 175, and then it is ready to rise again.

Benzinga发布 2026-09-23
《$AMD Joins $1T Club, NASDAQ ATH? | PreMarket Playbook | September 23, 2026》
$MRNA看涨
AI 摘要 · MRNA 因已突破的看涨三角旗而动能强劲;可能上行至 200 以上,但在 210-215 附近面临阻力,且技术上已超买。

AMJ Wellness Matters 提到了 Madna。我们之前稍微谈过这个。看看这里是怎么解决的。190 多。这只股票一直在交易。天哪,Madna 全是绿色蜡烛,无论是买入还是——抱歉,是价格和成交量都是。

AMJ Wellness Matters is mentioning Madna. We talked about that a little bit earlier. Let's see how that's resolved here. 190s. This kept trading. Oh man, Madna all green candles both buying or excuse me both price and volume.

是的,这是一个非常漂亮的牛市旗形形态的突破,这个形态是从八月开始的,当时我们得到了那条消息,我忘了具体是什么消息了,但我想是关于用 AI 个性化 mRNA 疫苗来应对癌症之类的东西。

Yeah, this is um this a really nice resolution of a bull penant uh formation that we had that started uh back in August when we got that news of I forget exactly what the news was, but is I think that regarding using AI personalized mRNA vaccines for things like cancer and stuff.

StockCharts TV发布 2026-09-22
《The BEST Chart in All 11 Sectors (September 2026)》
$MRNA看涨
AI 摘要 · MRNA的技术结构显示在跳空和整理后出现吸筹。

第一支箭,确切地说处于99.9百分位,是Moderna,代码是MRNA。显然,这个名字在新冠疫情期间已为我们许多人所熟悉。Moderna和Pfizer是值得关注的关键名字。

The first arrow, literally in the 99.9 percentile, is Moderna, its code is MRNA. Clearly, this name has become familiar to many of us during the COVID-19 pandemic. Moderna and Pfizer were key names to watch.

但看看这只股票在2026年是如何反弹的,以及它的上涨在最近一段时间里是如何显著加速的。六周。8月中旬,在一款药物获批之后出现了一个向上的大幅跳空缺口,此后价格进入盘整。

But look how this stock rebounded in 2026, and how its rise has accelerated remarkably in the recent period. Six weeks. A large price gap to the upside occurred in mid-August following the approval of a drug, and prices have since consolidated.

Benzinga发布 2026-09-21
《Oil Tanks, Futures Rally but 10-Year Nears 5% | PreMarket Playbook | September 21, 2026》
$MRNA看涨
AI 摘要 · MRNA看涨形态的突破目标为180以上,但因超买状况存在获利了结的可能。

接下来是MRNA。Bigab提到它今天在滚动。Moderna这里出现了11点的波动。这里是14、10%的波动。看Moderna开盘就猛拉。

MRNA is going to be next here. Bigab is mentioning that this is rolling here today. Like we had what an 11 point move here on Madna. 14 10% move here. Look at Madna ripping out of the gate here.

等一下。我得看看这个,因为我们之前讨论过它正在突破盘整。它当时在形成牛旗或者牛三角旗,现在就是这样。我们在往上走。看起来是多少,175?高点曾是1766。对我来说,这看起来像是这个看涨形态正在得到解决。这意味着我们可能最终会看到180,甚至更高。

Wait a minute. I got to look at this cuz we talked about how this was breaking out of consolidation. It was bull flagging and or bull penant and here we are. We are moving up. Uh looks like what is it 175?

So the high was 1766. Uh I mean to me this looks like we're getting a resolution of this bullish pattern here. And uh that means we'll probably end up seeing 180 maybe more.

Benzinga发布 2026-09-17
《Stocks Shrug Off A Hawkish Fed? | PreMarket Playbook + All Access | September 17, 2026》
$MRNA看涨
AI 摘要 · MRNA 正处于技术突破之中;130 是支撑位,175 是关键阻力位/突破目标。

Madna今天上涨超过10%。看看这个。它也突破了这一结构。我知道我们在这里经常谈论岛形。左侧肯定有价格历史。所以,这是一点。我们实际上从未回到这根K线的底部,但天哪,这个130看起来是相当不错的支撑。

现在看起来你的下一个目标可能是176。那就是Madna,MRNA。

Uh Madna up 10 plus percent here today. And look at this. This also breaking out of this structure. Now, I know we talk a lot about islands here. There's definitely price history to the left.

So, that's one thing. We never actually came back into the bottom of this candle, but boy oh boy, this 130 looked like some pretty good support. Now it actually looks like your next target here might be 176. That's Madna MRNA.

他说在等
价格走势相对于175这一水平的表现
突破175确认突破成立
近期市场价格走势
突破175支撑看涨突破论点;未能突破则削弱动能
Brian Shannon发布 2026-09-11
《Stock Market, Bitcoin, Gold Analysis for Week Ending 9/11/26》
$MRNA中性
AI 摘要 · MRNA 仍处于震荡状态,买方尚未掌控局面,但若区间收窄,有望重新领涨。

我们知道,基因学类股票几周前随着 mRNA 的走势把这一板块点燃了,而 mRNA 一直非常震荡。如果把锚点放在这一事件上,它基本上提供零价值,五日移动平均线在这一带上升。所以我认为,你看看它就会说,我们在 20 日移动平均线一带找到了买家。

周一可能是内包日,区间收窄,然后 MRNA 或许能够再次确立一些领涨地位,但现在说买家正在取得控制权还为时过早。

we know uh the genomics stocks kind of lit this group on fire a couple weeks ago with the mRNA move and mRNA has really just been you know very choppy. If we put an anchor on the event it provides zero value basically the fiveday moving average is rising in here.

So, I think that, you know, you look at it and say we found buyers along the 20-day moving average. Maybe an inside day on Monday, tighten the range, and then uh MRNA might be able to uh establish some leadership once again, but it's still a little bit too early uh to say that the buyers are gaining control in there.

Brian Shannon发布 2026-09-08
《Brian Shannon Trader TV Live 9/8/26》
$MRNA中性
AI 摘要 · MRNA即将迎来重大行情(火药桶),应很快得到解决。

关于mRNA是驱动因素的观点很好,因为那只股票感觉像一个即将爆炸的火药桶。就是这样。希望它很快发生并解决这个问题。我的意思是,我认为Moderna有一些优势,Moderna确实启动了这一切,你对此百分之百正确。

Good point about mRNA being the driver, because that stock feels like a powder keg about to explode. That's it. Hopefully, it happens soon and settles the matter. I mean, I think Moderna has something going for it, Moderna really set that in motion, and you were 100% right about that.

继续看更早 →
其他股票的全部观点条目
把 $MRNA 加入我的股票30 天完整试用
开始试用